| Indicators to assess aggregate RACF-level concordance | Corresponding Guideline recommendations |
---|---|---|
1 | Residents using antidepressants have documentation of moderate or severe major depressive disorder | CR 9 |
2 | Residents using antidepressants have documentation of individually targeted non-pharmacological management strategies that are currently in place | GPS 6 |
3 | Residents using antidepressants have documentation of informed consent for use of the antidepressant | GPS 8 |
4 | Residents using antidepressants have a documented date of next review for antidepressant treatment effectiveness | GPS 10 |
5 | Residents using antidepressants have a current antidepressant adverse event monitoring protocol in place | GPS 36 |
6 | Residents using antidepressants have used the current antidepressant for less than 6Â months | CR 11 |
7 | Residents using antidepressants for more than 6Â months are currently having the antidepressant dose tapered | GPS 37 |
8 | Residents using antidepressants for more than 6Â months and not currently tapering have documentation of a review of the harms and benefits of antidepressants continuation | CR 11 |